REMS programs. Megamergers. Generic encroachment. New sampling guidelines. The “unknowns” in the pharma industry have never been more prevalent or complex. But despite volumes of lagging prescription data and recall-based market research, pharma is still struggling to understand and anticipate how each new industry issue will impact current and future success. The key to understanding…
This past September, Med Ad News began its now-annual search for the future of pharmaceutical marketing. We sought out young companies to profile that are providing the most innovative and interesting products, services, or marketing opportunities to pharmaceutical companies and the healthcare community. After reviewing dozens of nominations, many of which were provided by our…
Just a few short years ago most doctors were technophobic. You would have been hard-pressed to get a physician to consider electronic prescribing or logging-on to web-based medical conference. What a difference a few years can make. According to Manhattan Research, in 2009 ,87% of US physicians are considered “ePharma” physicians. In others words, they…
In the upcoming November issue of Med Ad News, our sales-force effectiveness series continues with a technology round up, providing a catalogue of new and upgraded tech solutions for pharma sales forces. But technology is not only connecting healthcare professionals with pharmaceutical marketers. Physicians are connecting with their patients through digital channels as well. According…
It doesn’t take several years of post-graduate studies and a degree in medicine to describe what it’s like to live with a disease. From a patient’s perspective, the practical wisdom available in an embar-rassing anecdote, or a triumphant description of a breakthrough,can sometimes provide more value than any discussion to be had inside a doctor’s…